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Abstract
Aims The objective of the study was to evaluate whether the geriatric nutritional risk index (GNRI) at discharge may be help-
ful in predicting the long-term prognosis of patients hospitalized with heart failure (HF) with preserved ejection fraction
(HFpEF, left ventricular ejection fraction ≥50%), a common HF phenotype in the elderly.
Methods and results Overall, 110 elderly HFpEF patients (≥65 years) from the Ibaraki Cardiovascular Assessment Study-HF
(n = 838) were enrolled. The mean age was 78.5 ± 7.2 years, and male patients accounted for 53.6% (n = 59). All-cause mor-
tality was compared between the low GNRI (<92) with moderate or severe nutritional risk group and the high GNRI (≥92) with
no or low nutritional risk group. Cox proportional hazard regression models were constructed to evaluate the inﬂuence of the
GNRI on all-cause death with the following covariates using forward stepwise selection: age, sex, nutritional status based on
the GNRI as a categorical variable, history of HF hospitalization, haemoglobin level, estimated glomerular ﬁltration rate, log
brain natriuretic peptide levels (logBNP), history of hypertension, log C-reactive protein levels, left ventricular ejection fraction,
left ventricular mass index, and the New York Heart Association functional classiﬁcation (I/II or III class). The prognostic value
of the GNRI was compared with that of serum albumin using C-statistics. The GNRI was added to the logBNP, serum albumin or
the body mass index was added to the logBNP, and the C-statistic was compared using DeLong’s test. Cox regression analysis
revealed that age and a low GNRI were independent predictors of all-cause death (P < 0.05, n = 103; hazard ratio = 1.095, 95%
conﬁdence interval = 1.031–1.163, for age, and hazard ratio = 3.075, 95% conﬁdence interval = 1.244–7.600, for the GNRI).
DeLong’s test for the two correlated receiver operating characteristic curves [area under the receiver operating characteristic
curve (AUROC) of serum albumin, 0.71; AUROC of the GNRI, 0.75] demonstrated signiﬁcant differences between the groups
(P = 0.038). Adding the GNRI to the logBNP increased the AUROC for all-cause death signiﬁcantly (0.71 and 0.80, respectively;
P = 0.040, n = 105). The addition of serum albumin or the body mass index to the logBNP did not signiﬁcantly increase the
AUROC for all-cause death (P = 0.082 and P = 0.29, respectively).
Conclusions Nutritional screening using the GNRI at discharge is helpful to predict the long-term prognosis of elderly HFpEF
patients.
Keywords Brain natriuretic peptide; Heart failure with preserved ejection fraction; Inﬂammation; Nutritional screening;
Undernutrition
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Introduction
The prevalence of cardiovascular disorders has increased
markedly because of a rapidly ageing society and the western-
ization of lifestyle, both of which increase the risk of develop-
ing coronary artery disease and other cardiovascular disease.
The growing prevalence of heart failure (HF) is also an impor-
tant problem among the elderly because HF is observed pre-
dominantly in that population. According to the Acute
Decompensated Heart Failure Syndromes registry in Japan,
the mean age of patients with HF was 73.0 years, and 42.0%
were women.Moreover, almost half of the patients presented
a preserved ejection fraction (pEF), deﬁned as a left ventricu-
lar ejection fraction (LVEF) >40%, and the endpoint of 1 year
all-cause mortality was achieved in 17.0% of patients.1 In clin-
ical trial populations, the LVEF value used to deﬁne a ‘pEF’
ranged from 40 to 45%, and outcomes were better in patients
with HF with preserved ejection fraction (HFpEF) than in those
with a reduced ejection fraction (HFrEF).2 In previous studies,
the LVEF value used to deﬁne the ‘pEF’ ranged from 40 to 55%,
but current guidelines recommend a partition value of 50%.3–5
According to a recent analysis of a large national registry-
based cohort,6 cardiovascular and HF rehospitalizations rates
are higher for patients with HFrEF (LVEF ≤ 40%) and those with
HF with borderline ejection fraction (HFbEF) (LVEF 41–49%)
than for those with HFpEF (LVEF ≥ 50%). However, patients
with HFrEF, HFbEF, and HFpEF had very high rates of 5 year
mortality (75–76%) and rehospitalization (82–86%) rates,
which were similar. There are many effective treatment strat-
egies for patients with HFrEF; unfortunately, effective treat-
ment strategies for patients with HFpEF are lacking.
In HF patients, undernutrition is not uncommon7–15 and
represents one of the most signiﬁcant determinants of poor
clinical outcomes.7–17 The geriatric nutritional risk index
(GNRI) is a simple and well-established nutritional screening
tool for elderly HF patients.18–20 However, the predictive
value of the assessment of nutritional status using GNRI in
patients with HFpEF remains unclear.
In a multicentre registry setting, the present study evalu-
ated whether determining the GNRI at discharge may be
helpful to predict the long-term prognosis of patients hospi-
talized with HFpEF (LVEF ≥ 50%), a common HF phenotype
in the elderly population (≥65 years).
Methods
Study population
A total of 838 patients with HF symptoms were hospitalized
between June 2012 and March 2015 and were enrolled in
the Ibaraki Cardiovascular Assessment Study-HF registry.7,17,21
Follow-ups were conducted until 31 March 2016. The Ibaraki
Cardiovascular Assessment Study is a multicentre registry
study involving 11 hospitals in the Ibaraki Prefecture of
Japan. The Ibaraki Cardiovascular Assessment Study registry
inclusion criteria were patient age ≥20 years and the fulﬁlment
of the Framingham criteria for HF.22 The registry exclusion
criteria were age <20 years, not providing informed consent
to the attending physician, limited life expectancy due to ma-
lignant neoplasms, patients in whom the 2 year observation
was predicted to be impossible, and patients who were judged
as medically inappropriate by the attending physician. Written
informed consent was obtained from all patients, and data
collection for this study was approved by the institutional re-
view boards of the 11 participating hospitals. Additionally,
the Ibaraki Cardiovascular Assessment Study registry study
was conducted in accordance with the ethical principles of
the Declaration of Helsinki.
Data from the Ibaraki Cardiovascular Assessment Study reg-
istry were retrospectively analysed. Two parameters are used
to calculate the GNRI: serum albumin level and body mass in-
dex (BMI). We stratiﬁed the study patients into three groups:
HF patients with in-hospital death, HF patients who were
discharged after alleviation of symptoms, and HF patients
who were transferred elsewhere for continued medical care.7
Among the 838 patients enrolled in the registry, 590 patients
were aged ≥65 years and were discharged after alleviation of
symptoms. Seven patients on dialysis were excluded. Registry
patients for whom GNRI could not be estimated were also ex-
cluded (n = 187). Ultimately, a total of 110 HFpEF patients with
complete GNRI data were enrolled in this study (Figure 1).
Data collection
Baseline clinical data were collected for each patient. Patient-
related information collected at discharge included medical
history, laboratory test results, echocardiographic ﬁndings,
and prescriptions, and data were recorded in a computer da-
tabase. Blood tests were performed to determine
haemoglobin, sodium, serum creatinine, plasma brain natri-
uretic peptide (BNP), albumin, total cholesterol, and C-
reactive protein levels. The estimated glomerular ﬁltration
rate (eGFR) was calculated using the following formula:
eGFR = 194 × serum creatinine1.094 × age in years0.287 for
male patients. The adjusted eGFR value for female patients
was calculated using the following formula: eGFR fe-
male = eGFR × 0.739.23 The BMI was calculated as body weight
in kilogrammes divided by the square of the height in metres.
Assessment of nutritional status using geriatric
nutritional risk index
The GNRI was developed by Bouillanne et al.24 as a screening
tool for undernutrition in a hospital population. In the
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present study, the GNRI was calculated from serum albumin
and BMI obtained at discharge. We adopted Kinugasa’s mea-
surement method18 as follows:
GNRI ¼ 14:89serum albumin g=dLð Þ
þ 41:7present body weight= heightð Þ2 m2ð Þ22 
¼ 14:89serum albumin g=dLð Þ þ 41:7BMI=22:
BMI/22 was set to 1 when the patient’s BMI/22 was greater
than 1.
The GNRI cut-off values were also adopted from the study
by Bouillanne et al.24 From these GNRI values, four grades of
nutrition-related risk were deﬁned: major risk (GNRI < 82),
moderate risk (GNRI 82 to <92), low risk (GNRI 92 to <98),
and no risk (GNRI ≥ 98). In the present study, we deﬁned the
GNRI cut-off value as 92. Clinical characteristics and mortality
were compared between the low GNRI (<92) with moderate
or severe nutritional risk group and the high GNRI (≥92) with
low or no nutritional risk, according to previous reports.18,19,25
Correlation between brain natriuretic peptide
levels and nutritional status
The correlation between the GNRI as a continuous variable
and the logarithmically transformed plasma BNP (logBNP)
level was evaluated. Blood was collected into tubes
containing ethylenediaminetetraacetic acid, and plasma
BNP concentrations were measured using a validated and
commercially available immunoassay kit (Tosoh Co. Ltd.,
Tokyo, Japan). The upper limit of normal plasma BNP level
was 18.4 pg/mL. The minimal and maximal detectable
levels of BNP were 4 and 2000 pg/mL, respectively.
Assessment of prognosis using the geriatric
nutritional risk index
We divided the study patients into two groups: (i) HFpEF pa-
tients with low or no nutritional risk (patients with a GNRI of
Figure 1 Study ﬂow diagram. We included a total of 110 elderly heart failure (HF) with preserved ejection fraction (HFpEF) patients with geriatric nu-
tritional risk index (GNRI) data. Low GNRI, group of HFpEF patients with moderate or severe nutritional risk; high GNRI, group of HFpEF patients with
low or no nutritional risk.
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≥92) and (ii) HFpEF patients with moderate or severe nutri-
tional risk (patients with GNRI of <92).
We investigated whether nutritional status assessed using
the GNRI was associated with all-cause death and cardiovas-
cular death. Cardiovascular death was deﬁned as death at-
tributable to cardiovascular origin.
Assessment of heart failure with preserved
ejection fraction
Heart failure with preserved ejection fraction was deﬁned as
follows: (i) presence of HF symptoms deﬁned by the Framing-
ham criteria22; (ii) preserved LVEF ≥ 50%, as previously de-
scribed3–5; and (iii) absence of HF aetiologies, including
severe valve disease, congenital disease, hypertrophic cardio-
myopathy, acute myocarditis, cardiac amyloidosis, pericardial
disease, primary pulmonary hypertension, or acute myocar-
dial infarction.
Statistical analysis
Continuous variables were expressed as mean ± standard
deviation if normally distributed and as median [inter-quar-
tile range (IQR)] if non-normally distributed. Differences be-
tween the two groups were compared using an unpaired
Student’s t-test or a Mann–Whitney U test, as appropriate.
The chi-squared test was used to compare categorical vari-
ables. Pearson’s correlation analysis was used to evaluate
the correlation between the GNRI and the logBNP or log
C-reactive protein concentration. A partial correlation anal-
ysis was performed between the GNRI and the logBNP
while controlling for the eGFR. Kaplan–Meier analysis with
the log-rank test was performed to determine whether nu-
tritional screening using GNRI at discharge could be helpful
in predicting long-term prognosis in patients hospitalized
with HFpEF. In addition, a Cox proportional hazards model
analysis was performed to determine the signiﬁcant predic-
tors of prognosis. To evaluate the inﬂuence of the GNRI on
all-cause death, the following four Cox proportional hazard
regression models were constructed: Model 1, unadjusted;
Model 2, age and sex adjusted; and Model 3, age and
logBNP adjusted. In Model 4, the following covariates were
included using forward stepwise selection: age, sex, nutri-
tional status based on the GNRI as a categorical variable,
previous history of HF hospitalization, haemoglobin level,
eGFR, logBNP, history of hypertension, log C-reactive pro-
tein, LVEF, left ventricular mass index, and New York Heart
Association (NYHA) functional classiﬁcation (I/II or III class).
The prognostic value of the GNRI was compared with that
of serum albumin using the C-statistic. We added the GNRI
to the logBNP or the model of age and logBNP and com-
pared the C-statistics using DeLong’s test. We also added
the serum albumin or BMI to the logBNP and compared
the C-statistics using DeLong’s test. As a severity
assessment of HF, the BNP value is very useful; it is gener-
ally known that the BNP value at the post-stability phase
has a stronger prognostic ability than the value at the time
of admission. A P-value of <0.05 was considered statisti-
cally signiﬁcant. All statistical analyses except the C-
statistics were performed using StatView 5.0 (SAS Institute
Inc., Cary, NC, USA), SPSS version 24 (IBM Corp., Armonk,
NY, USA), or EZR version 1.37 (Saitama Medical Center,
Jichi Medical University, Saitama, Japan) for Windows.
Statistical analysis using C-statistics of the results was
performed by R software package (version 3.3.3, R
Development Core Team, https://www.r-project.org/).
Results
Clinical characteristics of study patients
Tables 1 and 2 show the clinical characteristics of the HFpEF
patients with GNRI data according to the risk of undernutri-
tion. At the time of admission, based on the NYHA functional
classiﬁcation, 10 patients were classiﬁed as Class II, 38 pa-
tients as Class III, and 62 patients as Class IV. Conversely, at
the time of discharge, based on the NYHA functional classiﬁ-
cation, 52 patients were classiﬁed as Class I, 52 patients as
Class II, and 6 patients as Class III. None of the patients were
classiﬁed as Class IV. The median plasma BNP level of the
overall study population was 206.9 (IQR 105.7–355.1)
pg/mL, and as the distribution of BNP levels was highly
skewed, we normalized the data through a logarithmic trans-
formation. The median GNRI of the overall study population
was 93.8 (IQR 84.9–98.3). Of the 110 enrolled HFpEF patients
for whom GNRI could be calculated, 73 (66.4%) had low-to-
major nutrition-related risks (low, 21.8%; moderate, 23.6%;
and major, 20.9%) at discharge.
The 110 HFpEF patients in the study population were
categorized as follows: HFpEF patients with low GNRI
(<92, n = 49) with moderate or major nutrition-related risk
and patients with high GNRI (≥92, n = 61) with low or no
nutrition-related risk. The clinical characteristics of the pa-
tients enrolled in the two groups are also shown in Tables
1 and 2. Patients’ age, weight, BMI, hypertension history,
haemoglobin level, plasma BNP level, serum albumin level,
total cholesterol level, C-reactive protein level, left ventric-
ular mass index, and LVEF differed signiﬁcantly between
the two groups. However, factors such as sex, NYHA class,
systolic blood pressure, heart rate, smoking status, HF-
related admission history, population of HF patients with
ischaemic aetiology, dyslipidaemia, diabetes mellitus,
chronic obstructive pulmonary disease, cerebrovascular dis-
ease, sodium level, eGFR, left ventricular end-diastolic di-
ameter, left atrial volume index, E/mean E0, and the use
of diuretics, angiotensin-converting enzyme inhibitors
and/or angiotensin II receptor blockers, beta-blockers, and
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statins did not differ signiﬁcantly between the two groups.
When the log C-reactive protein level was plotted against
the GNRI as a continuous variable for the overall patient
population, there was a weak signiﬁcant inverse correlation
(r = 0.287, P = 0.002, n = 110), indicating that a greater
increase in GNRI was associated with a greater decrease
in C-reactive protein levels.
Correlation between brain natriuretic peptide
levels and nutritional status
When the logBNP was plotted against the GNRI as a contin-
uous variable for the overall patient population, there was
a weak signiﬁcant inverse correlation (r = 0.30,
P = 0.002, n = 105), indicating that a greater increase in
GNRI was associated with a greater decrease in plasma
BNP levels. After controlling for eGFR, the association
between the GNRI and the logBNP persisted
(r [partial] = 0.285, P = 0.003, n = 105).
Impact of nutritional screening using geriatric
nutritional risk index for all-cause death
During the follow-up period (503.5 [IQR 328.0–790.0] days),
24 deaths occurred. Of these, 14 patients (58.3%) had a
cardiovascular death: HF death (n = 7, 29.2%), sudden death
(n = 4, 16.7%), and death due to other reasons (n = 3, 12.5%).
Ten patients (41.7%) experienced non-cardiovascular-related
(n = 8) or unknown (n = 2) deaths.
The Kaplan–Meier analysis revealed that all-cause deaths
occurred more frequently in HFpEF patients with a low
GNRI (n = 17) compared with HFpEF patients with a high
GNRI (n = 7) (log-rank P < 0.001). Table 3 shows the im-
pact of nutritional screening using GNRI on all-cause death.
The analysis revealed that HFpEF patients with a low GNRI
had an increased risk of all-cause death compared with pa-
tients in the high GNRI group (P < 0.05) but not in Model
3 (Table 3). In Model 4, the multivariate Cox regression
analysis using forward stepwise selection revealed that
age and a low GNRI as a categorical variable were indepen-
dent predictors of all-cause death [P < 0.05, n = 103; haz-
ard ratio (HR) = 1.095, 95% conﬁdence interval
(CI) = 1.031–1.163, for age, and HR = 3.075, 95% CI = 1.244–
7.600, for the GNRI]. After adjusting for age, all-cause
deaths occurred more frequently in HFpEF patients with a
low GNRI compared with HFpEF patients with a high GNRI
(P = 0.009, n = 110; HR = 3.334; 95% CI = 1.354–8.207)
(Figure 2). The Cox proportional hazard analyses also re-
vealed that each per point increase in the GNRI was asso-
ciated with a decreased risk of all-cause death (Table 3).
In Model 3, using the GNRI as a continuous variable, Cox
proportional hazard analyses also revealed that advanced
Table 1 Clinical characteristics of the patients by GNRI
Overall
(n = 110)
High GNRI
(≥92) (n = 61)
Low GNRI
(<92) (n = 49) P-value
Age (years) 78.5 ± 7.2 77.0 ± 6.5 80.4 ± 7.7 0.016
Male, n (%) 59 (53.6) 30 (49.2) 29 (59.2) 0.34
NYHA (2/3/4) on admission 10/38/62 5/23/33 5/15/29 0.73
NYHA (3 or 4) on admission, n (%) 100 (90.9) 56 (91.8) 44 (89.8) 0.75
Clinical scenarios (1/2/3/4/5) on admission 67/39/3/0/1 40/17/3/0/1 27/22/0/0/0 —
NYHA (1/2/3) at discharge 52/52/6 26/32/3 26/20/3 —
NYHA (1 or 2) at discharge, n (%) 104 (94.5) 58 (95.1) 46 (93.9) 1
Weight (kg) at discharge 55.6 ± 11.1 59.8 ± 9.5 50.3 ± 10.7 <0.001
BMI (kg/m2) at discharge 23.1 ± 4.1 25.0 ± 3.5 20.6 ± 3.5 <0.001
BMI (kg/m2) <18.5 at discharge, n (%) 10 (9.1) 0 (0) 10 (20.4) <0.001
BMI (kg/m2) <22.0 at discharge, n (%) 47 (42.7) 12 (19.7) 35 (71.4) <0.001
SBP (mmHg) at discharge 120.0 [108.0–130.3] 120.0 [108.0–126.8] 121.5 [108.0–136.0] 0.81
Heart rate (b.p.m.) at discharge 64.5 [58.0–71.0] 64.0 [56.0–69.0] 65.0 [58.8–75.3] 0.182
Medical history
Current or past smoker, n (%) 55 (50.0) 30 (49.2) 25 (51.0) 1
Readmission count for HF (0/1/2/≥3) 81/12/7/10 45/6/5/5 36/6/2/5 —
Previous history of HF hospitalization, n (%) 29 (26.4) 16 (26.2) 13 (26.5) 1
HF aetiology, ischaemic, n (%) 28 (25.5) 13 (21.3) 15 (30.6) 0.28
Atrial ﬁbrillation, n (%) 36 (32.7) 22 (36.1) 14 (28.6) —
Hypertension, n (%) 83 (75.5) 51 (83.6) 32 (65.3) 0.044
Dyslipidaemia, n (%) 43 (39.1) 28 (45.9) 15 (30.6) 0.119
Diabetes mellitus, n (%) 54 (49.1) 31 (50.8) 23 (46.9) 0.71
COPD, n (%) 8 (7.3) 4 (6.6) 4 (8.2) 1
Cerebrovascular disease, n (%) 12 (10.9) 10 (16.4) 2 (4.1) 0.062
BMI, body mass index; COPD, chronic obstructive pulmonary disease; GNRI, geriatric nutritional risk index; HF, heart failure; n, number of
patients; NYHA, New York Heart Association; SBP, systolic blood pressure.
Results are expressed as mean ± standard deviation or the median [inter-quartile range]. Data were missing for the following character-
istics: SBP, for six HF patients with high GNRI and three HF patients with low GNRI. ‘Atrial ﬁbrillation’ demonstrates the rhythm at
discharge.
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age and higher logBNP were associated with an increased
risk of all-cause death (HR = 1.081, 95% CI = 1.018–1.147,
for age; HR = 4.872, 95% CI = 1.358–17.477, for logBNP).
In addition, the Kaplan–Meier analysis also revealed that
cardiovascular deaths occurred more frequently in
HFpEF patients with a low GNRI (n = 9) compared with
HFpEF patients with a high GNRI (n = 5) (P = 0.025 by
the log-rank test).
Comparison with other nutritional indices
The C-statistic of the GNRI was compared with that of se-
rum albumin to assess its validity as a nutritional risk
screening tool in elderly patients hospitalized with HFpEF
(Figure 3). DeLong’s test for two correlated receiver operat-
ing characteristic curves [area under the receiver operating
characteristic curve (AUROC) of serum albumin, 0.71;
Table 3 Impact of nutritional screening using GNRI on all-cause death
No. of events
(all-cause
deaths)/
at risk (%)
Model 1: unadjusted
Model 2: adjusted
for age and sex
No. of events
(all-cause
deaths)/
at risk (%)
Model 3: adjusted
for age and logBNP
HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
GNRI
Low vs. high
(high as per
reference)a
24/110 (21.8) 4.311
(1.784–10.415)
0.001 3.202
(1.295–7.918)
0.012 24/105 (22.9) 2.444
(0.953–6.267)
0.063
GNRI as a
continuous
variable
0.912
(0.877–0.949)
<0.001 0.927
(0.889–0.967)
<0.001 0.921
(0.880–0.964)
<0.001
BNP, brain natriuretic peptide; CI, conﬁdence interval; GNRI, geriatric nutritional risk index; HR, hazard ratio.
Data were missing for the following characteristics: logBNP for ﬁve patients.
aPrimary outcomes are presented as HR for the low GNRI (<92) using the high GNRI (≥92) as a reference.
Table 2 Laboratory data, echocardiographic data, and medications at discharge by GNRI
Overall
(n = 110)
High GNRI
(≥92) (n = 61)
Low GNRI
(<92) (n = 49) P-value
Laboratory measurement at discharge
Haemoglobin (g/dL) 11.5 ± 2.2 12.0 ± 2.3 10.8 ± 1.9 0.006
Sodium (mEq/L) 139.1 ± 3.7 139.2 ± 3.3 138.9 ± 4.1 0.64
Estimated GFR (mL/min/1.73 m2) 41.5 [31.8–56.0] 43.4 [32.8–54.9] 36.4 [25.6–56.6] 0.36
Estimated GFR <60 (mL/min/1.73 m2), n (%) 91 (82.7) 52 (85.2) 39 (79.6) 0.46
BNP (pg/mL) 206.9 [105.7–355.1] 126.3 [76.0–264.9] 297.0 [147.6–478.3] <0.001
logBNP 2.26 ± 0.40 2.12 ± 0.42 2.42 ± 0.32 0.001
Albumin (g/dL) 3.60 [3.20–3.90] 3.80 [3.60–4.20] 3.10 [2.75–3.33] <0.001
Total cholesterol (mg/dL) 167.1 ± 34.7 175.2 ± 34.3 155.9 ± 32.5 0.007
C-reactive protein (mg/dL) 0.36 [0.16–0.92] 0.29 [0.15–0.56] 0.47 [0.19–1.77] 0.015
GNRI 93.8 [84.9–98.3] 98.3 [95.3–104.2] 84.5 [77.3–88.4] <0.001
Echocardiography at discharge
LVDd (mm) 49.2 ± 5.9 48.6 ± 5.8 50.0 ± 6.0 0.22
Left atrial volume index (mL/m2) 48.5 [36.4–61.5] 51.7 [38.1–61.8] 44.3 [33.1–56.5] 0.162
Left atrial volume index >34 (mL/m2), n (%) 86 (78.2) 51 (83.6) 35 (71.4) 0.164
LVMI (g/m2) 119.4 ± 35.0 113.0 ± 34.4 127.3 ± 34.4 0.033
E/mean E0 13.4 [11.0–17.7] 13.5 [11.1–17.5] 13.0 [10.3–18.4] 0.79
LVEF (%) 60.0 [54.1–66.5] 61.6 [55.9–68.7] 58.3 [53.2–64.7] 0.034
Medication at discharge
Diuretics, n (%) 96 (87.3) 54 (88.5) 42 (85.7) 0.78
Loop diuretics, n (%) 87 (79.1) 49 (80.3) 38 (77.6) 0.81
Thiazide diuretics, n (%) 10 (9.1) 6 (9.8) 4 (8.2) 1
Tolvaptan, n (%) 8 (7.3) 5 (8.2) 3 (6.1) 0.73
Aldosterone antagonist, n (%) 59 (53.6) 36 (59.0) 23 (46.9) 0.25
ACEIs/ARBs, n (%) 71 (64.5) 42 (68.9) 29 (59.2) 0.32
Beta-blocker, n (%) 78 (70.9) 40 (65.6) 38 (77.6) 0.21
Statin, n (%) 44 (40) 29 (47.5) 15 (30.6) 0.081
ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin II receptor blockers; BNP, brain natriuretic peptide; GFR, glomerular
ﬁltration rate; GNRI; geriatric nutritional risk index; LVDd, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction;
LVMI, left ventricular mass index; n, number of patients.
Results are expressed as mean ± standard deviation or the median [inter-quartile range]. Data were missing for the following character-
istics: BNP, for four heart failure patients with high GNRI and for one heart failure patient with low GNRI; total cholesterol, for six heart
failure patients with high GNRI and nine heart failure patients with low GNRI; LVMI, for one heart failure patient with high GNRI and
for one heart failure patient with low GNRI; and E/mean E0, for six heart failure patients with high GNRI.
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AUROC of the GNRI, 0.75] demonstrated signiﬁcant differ-
ences between the two groups (P = 0.038). We assessed
whether the evaluation of the GNRI levels in addition to
the other predictor improved the stratiﬁcation of the risk of
mortality in elderly patients hospitalized with HFpEF. Adding
the GNRI to the logBNP increased the AUROC for all-cause
death signiﬁcantly (0.71 and 0.80, respectively; P = 0.040,
n = 105). However, adding the GNRI to the model of age and
logBNP did not signiﬁcantly increase the AUROC for all-cause
death (0.78 and 0.81, respectively; P = 0.197, n = 105).
Conversely, adding serum albumin levels or BMI to the logBNP
did not signiﬁcantly increase the AUROC for all-cause death
(P = 0.082 and P = 0.29, respectively).
Discussion
In the present study, patient nutritional status, assessed
using the GNRI at discharge, was examined to determine its
usefulness in predicting the long-term prognosis of patients
hospitalized with HF in a multicentre registry setting. Our re-
sults showed that all-cause death occurred more frequently
in HFpEF patients with moderate or major nutrition-related
risk than in those with low or no nutrition-related risk (Table 3
and Model 4). Evidence in support of a lower GNRI at dis-
charge as a signiﬁcant predictor of the occurrence of all-cause
death in patients hospitalized with HFpEF includes the follow-
ing: a per point increase in the GNRI was associated with a
lower risk of all-cause death (Table 3). The results of the pres-
ent study indicate that screening nutritional status using a
GNRI at discharge further reﬁnes risk assessment in patients
hospitalized with HFpEF.
Undernutrition is known as one of the most critical deter-
minants of poor clinical outcomes in HF patients.7–20 How-
ever, to our knowledge, all but one18 of the previous
studies reported on so-called HF patients, and therefore,
our speciﬁc ﬁndings for ‘HFpEF patients’ are novel. Kinugasa
et al.18 reported that malnutrition assessed by the GNRI on
admission was an independent determinant of long-term
death in acute HF with pEF. This ﬁnding18 supports those of
the present study, which demonstrated that a lower GNRI is
a signiﬁcant predictor of the occurrence of all-cause death
in patients hospitalized with HFpEF.
Fluid status, in particular, has been shown to inﬂuence se-
rum albumin levels and the BMI. Increased extracellular ﬂuid
volume decreases serum albumin, whereas it increases BMI.
Considering such a counteracting effect, the GNRI, which is a
combined index of albumin and BMI, may lead to a minimiza-
tion of the effect of ﬂuid status. However, the inﬂuence of se-
rum albumin and BMI may inﬂuence the calculation of GNRI,
as GNRI might prefer the stable state. In addition, HFpEF has
been variably classiﬁed as LVEF > 40, >45, >50, and ≥55%.4
Currently, HF patients with an ejection fraction in the range
of 41–49% are allocated to HFbEF.4 HFbEF patients present a
mild systolic dysfunction, but in the clinical setting, there are
many cases with a similar pathophysiology as HFpEF.5 There-
fore, HFbEF patients are often treated with guideline-directed
Figure 2 Survival curve adjusted for age. After adjusting for age, the
analysis revealed that heart failure with preserved ejection fraction
(HFpEF) patients with a low geriatric nutritional risk index (GNRI) had
an increased risk of all-cause death compared with patients in the high
GNRI group (P = 0.009, n = 110; hazard ratio = 3.334; 95% conﬁdence in-
terval = 1.354–8.207). Low GNRI, group of HFpEF patients with moderate
or severe nutritional risk; high GNRI, group of HFpEF patients with low or
no nutritional risk.
Figure 3 Predictive performance of serum albumin and the geriatric nu-
tritional risk index (GNRI) for all-cause death. AUC, area under the curve.
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medical therapy that is similar to that used in patients with
HFpEF,4 whereas efﬁcient therapeutic agents for HFpEF are
poorly established. However, unlike for HFpEF, sufﬁcient
evidence-based therapy for HFrEF patients may also be effec-
tive for HFbEF patients.5 For example, in patients with HFbEF,
data suggest that HFrEF therapeutic agents such as beta-
blockers are also effective.26 According to Tsuji et al., the prog-
nostic impacts of these agents in HFbEF differ from those in
HFpEF but are almost comparable with those in HFrEF. Thus,
the use of beta-blockers has been positively associated, and
the use of diuretics has been negatively associated with im-
proved mortality in HFbEF and HFrEF but not in HFpEF pa-
tients.26 The HFpEF criterion used in the study by Kinugasa
et al.18 was LVEF ≥ 40% and included HFbEF. Conversely, in
our study, the HFpEF criterion was LVEF ≥ 50% and did not in-
clude HFbEF. Unfortunately, there are a lack of effective treat-
ment strategies for patients with HFpEF, and the investigation
of the potential predictive value of nutritional status assess-
ment using the GNRI in patients with HFpEF is important.
Inﬂammation may play an important role in the pathogen-
esis of HFpEF owing to its signiﬁcant contribution to myocar-
dial ﬁbrosis.27 Koller et al.27 reported that C-reactive protein
was a strong prognostic marker for risk stratiﬁcation in pa-
tients with HFpEF. Recently, in emerging pathophysiological
models of HFpEF, systemic microvascular endothelial inﬂam-
mation related to coexisting conditions has been proposed
as an additional mechanism leading to myocardial inﬂamma-
tion and ﬁbrosis, increased oxidative stress, and alterations in
cardiomyocyte signalling pathways.28 These alterations pro-
mote cardiomyocyte remodelling and dysfunction, in addition
to microvascular dysfunction and rarefaction in cardiac and
skeletal muscle.28 Conversely, the GNRI was developed as a
screening tool to assess not only the nutritional but also the
inﬂammatory status of older inpatients.29 The GNRI has been
shown to correlate well with indicators of inﬂammation and
length of hospital stay.29 Indeed, in the present study, the
C-reactive protein level was signiﬁcantly higher in the moder-
ate or major nutrition-related risk group (low GNRI, 0.47 [IQR
0.19–1.77]) than in the low or no nutrition-related risk group
(high GNRI, 0.29 [IQR 0.15–0.56], P< 0.05). In addition, when
the log C-reactive protein was plotted against the GNRI as a
continuous variable in the overall patient population, there
was a weak but signiﬁcant inverse correlation (r = 0.287,
P = 0.002, n = 110), indicating that a greater increase in GNRI
would be associated with a greater decrease in C-reactive
protein levels. Intestinal oedema or anorexia-induced low nu-
tritional intake, liver dysfunction, cytokine-induced hyperca-
tabolism, insulin resistance, and other mechanisms may all
lead to HF-related undernutrition.12 HF patients with under-
nutrition enter a vicious cycle of inﬂammation, catabolic
drive, and undernutrition, which further exacerbates HF.30
Unfortunately, because effective treatment options are cur-
rently unavailable for HFpEF, this might be considered a valu-
able target for intervention in the future.
Several limitations of the present study should be men-
tioned. The total number of HFpEF patients enrolled in the
Ibaraki Cardiovascular Assessment Study registry and the
number of all-cause deaths and cardiovascular death events
were not large. Therefore, the number of indices that could
be incorporated into the Cox proportional hazard regression
models was small. In addition, we did not exclude co-morbid
diseases such as nephrotic syndrome, liver cirrhosis, cancer,
collagen disease, the presence of infectious diseases, and
blood disorders, all of which may affect albumin levels. In
general, female HFpEF patients have occupied two thirds of
the entire HFpEF study population.31 Conversely, in some co-
hort studies, female HFpEF patients represented only 48–50%
of the entire HFpEF patient population.32,33 Similarly, in our
sample, there was a lower number of women (46%) enrolled,
which is in contrast with the epidemiology of HFpEF in the
real-world setting. Because our study differs from a complete
case registration study, the proportion of female patients
with HFpEF was likely lower.
Conclusions
This multicentre registry study suggests that nutritional
screening using GNRI at discharge from hospital is helpful in
predicting the long-term prognosis of elderly patients hospi-
talized with HFpEF.
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